Published in Wiley Interdiscip Rev RNA on May 02, 2011
Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res (2011) 1.84
Cellular microRNAs up-regulate transcription via interaction with promoter TATA-box motifs. RNA (2014) 0.96
Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther (2012) 0.94
Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J (2012) 0.93
Chromatin remodeling by the small RNA machinery in mammalian cells. Epigenetics (2013) 0.92
RNA-mediated gene activation. Epigenetics (2013) 0.92
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol Ther Nucleic Acids (2012) 0.91
microRNAs in cancer cell response to ionizing radiation. Antioxid Redox Signal (2014) 0.90
Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases. Br J Cancer (2014) 0.87
miRNA goes nuclear. RNA Biol (2012) 0.87
New perspectives on the diversification of the RNA interference system: insights from comparative genomics and small RNA sequencing. Wiley Interdiscip Rev RNA (2013) 0.84
Small RNA and its application in andrology and urology. Transl Androl Urol (2012) 0.84
Identification of miRNAs that modulate glucocerebrosidase activity in Gaucher disease cells. RNA Biol (2014) 0.83
Regulation of mammalian transcription and splicing by Nuclear RNAi. Nucleic Acids Res (2015) 0.83
Classical non-homologous end-joining pathway utilizes nascent RNA for error-free double-strand break repair of transcribed genes. Nat Commun (2016) 0.83
MicroRNA 140 Promotes Expression of Long Noncoding RNA NEAT1 in Adipogenesis. Mol Cell Biol (2015) 0.82
Dicer-dependent biogenesis of small RNAs derived from 7SL RNA. PLoS One (2012) 0.81
A New Double Stranded RNA Suppresses Bladder Cancer Development by Upregulating p21 (Waf1/CIP1) Expression. Biomed Res Int (2015) 0.80
Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev (2014) 0.80
Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer. Cell Rep (2016) 0.80
Upregulating endogenous genes by an RNA-programmable artificial transactivator. Nucleic Acids Res (2015) 0.79
Targeted p53 activation by saRNA suppresses human bladder cancer cells growth and metastasis. J Exp Clin Cancer Res (2016) 0.79
The Role of microRNAs in Stemness of Cancer Stem Cells. Oncol Rev (2013) 0.78
Small activating RNA restores the activity of the tumor suppressor HIC-1 on breast cancer. PLoS One (2014) 0.78
Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J (2016) 0.78
Human RNAi pathway: crosstalk with organelles and cells. Funct Integr Genomics (2013) 0.77
Inducing gene expression by targeting promoter sequences using small activating RNAs. J Biol Methods (2015) 0.77
Small double-stranded RNA mediates the anti-cancer effects of p21WAF1/ClP1 transcriptional activation in a human glioma cell line. Yonsei Med J (2014) 0.76
Analysis of Serum MicroRNAs as Potential Biomarker in Coronary Bifurcation Lesion. Dis Markers (2015) 0.76
RNA activation of haploinsufficient Foxg1 gene in murine neocortex. Sci Rep (2016) 0.75
Reactivation of HIC-1 gene by saRNA inhibits clonogenicity and invasiveness in breast cancer cells. Oncol Lett (2014) 0.75
Identification of the Drosophila X chromosome: The long and short of it. RNA Biol (2015) 0.75
Small activating RNA induces myogenic differentiation of rat adipose-derived stem cells by upregulating MyoD. Int Braz J Urol (2015) 0.75
A ceRNA approach may unveil unexpected contributors to deletion syndromes, the model of 5q- syndrome. Oncoscience (2015) 0.75
RNA Activation of the Vascular Endothelial Growth Factor Gene (VEGF) Promoter by Double-Stranded RNA and Hypoxia: Role of Noncoding VEGF Promoter Transcripts. Mol Cell Biol (2016) 0.75
Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy. Cancer Gene Ther (2016) 0.75
Up-regulation of p16 by miR-877-3p inhibits proliferation of bladder cancer. Oncotarget (2016) 0.75
Size unbiased representative enzymatically generated RNAi (SURER) library and application for RNAi therapeutic screens. Nucleic Acid Ther (2014) 0.75
Evaluating the involvement and interaction of abscisic acid and miRNA156 in the induction of anthocyanin biosynthesis in drought-stressed plants. Planta (2017) 0.75
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (2001) 57.23
The transcriptional landscape of the mammalian genome. Science (2005) 37.63
MicroRNA targets in Drosophila. Genome Biol (2003) 23.59
Argonaute2 is the catalytic engine of mammalian RNAi. Science (2004) 22.86
The lin-4 regulatory RNA controls developmental timing in Caenorhabditis elegans by blocking LIN-14 protein synthesis after the initiation of translation. Dev Biol (1999) 17.82
Regulation of heterochromatic silencing and histone H3 lysine-9 methylation by RNAi. Science (2002) 17.04
Switching from repression to activation: microRNAs can up-regulate translation. Science (2007) 17.00
Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science (2005) 16.84
Antisense transcription in the mammalian transcriptome. Science (2005) 15.69
Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell (2005) 15.26
Long noncoding RNA as modular scaffold of histone modification complexes. Science (2010) 15.23
Rational siRNA design for RNA interference. Nat Biotechnol (2004) 14.16
A distinct small RNA pathway silences selfish genetic elements in the germline. Science (2006) 11.63
Passenger-strand cleavage facilitates assembly of siRNA into Ago2-containing RNAi enzyme complexes. Cell (2005) 9.35
A novel class of small RNAs bind to MILI protein in mouse testes. Nature (2006) 8.80
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol (1991) 8.60
Characterization of the piRNA complex from rat testes. Science (2006) 7.86
Killing the messenger: short RNAs that silence gene expression. Nat Rev Mol Cell Biol (2003) 7.38
Small interfering RNA-induced transcriptional gene silencing in human cells. Science (2004) 7.29
MicroRNA-10a binds the 5'UTR of ribosomal protein mRNAs and enhances their translation. Mol Cell (2008) 6.58
Argonaute2 cleaves the anti-guide strand of siRNA during RISC activation. Cell (2005) 6.47
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2. Cell (2007) 5.87
A novel class of small RNAs in mouse spermatogenic cells. Genes Dev (2006) 5.85
A hexanucleotide element directs microRNA nuclear import. Science (2007) 5.71
RNA-directed de novo methylation of genomic sequences in plants. Cell (1994) 5.26
Introns increase transcriptional efficiency in transgenic mice. Proc Natl Acad Sci U S A (1988) 5.18
E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Cancer Res (1995) 5.11
Activating gene expression in mammalian cells with promoter-targeted duplex RNAs. Nat Chem Biol (2007) 5.05
Argonaute-1 directs siRNA-mediated transcriptional gene silencing in human cells. Nat Struct Mol Biol (2006) 4.93
Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A (2006) 4.90
Complex transcriptional units: diversity in gene expression by alternative RNA processing. Annu Rev Biochem (1986) 4.73
Tiny RNAs associated with transcription start sites in animals. Nat Genet (2009) 4.19
MicroRNA-directed transcriptional gene silencing in mammalian cells. Proc Natl Acad Sci U S A (2008) 4.16
Promoter-associated RNA is required for RNA-directed transcriptional gene silencing in human cells. Proc Natl Acad Sci U S A (2007) 3.99
The RNAi revolution. Nature (2004) 3.96
An epigenetic activation role of Piwi and a Piwi-associated piRNA in Drosophila melanogaster. Nature (2007) 3.86
Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition. Science (1992) 3.53
Involvement of AGO1 and AGO2 in mammalian transcriptional silencing. Nat Struct Mol Biol (2006) 3.46
Structure, function and evolution of CpG island promoters. Cell Mol Life Sci (2003) 3.09
Antisense transcripts are targets for activating small RNAs. Nat Struct Mol Biol (2008) 3.02
Intricate combinatorial patterns of exon splicing generate multiple regulated troponin T isoforms from a single gene. Cell (1985) 3.02
Germline E-cadherin gene (CDH1) mutations predispose to familial gastric cancer and colorectal cancer. Hum Mol Genet (1999) 2.41
A multifunctional human Argonaute2-specific monoclonal antibody. RNA (2008) 2.17
Deep sequencing of human nuclear and cytoplasmic small RNAs reveals an unexpectedly complex subcellular distribution of miRNAs and tRNA 3' trailers. PLoS One (2010) 2.12
Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell (2009) 2.05
Fluorescence correlation spectroscopy and fluorescence cross-correlation spectroscopy reveal the cytoplasmic origination of loaded nuclear RISC in vivo in human cells. Nucleic Acids Res (2008) 2.01
Expanded RNA-binding activities of mammalian Argonaute 2. Nucleic Acids Res (2009) 1.94
Genetic analysis of RNA-mediated transcriptional gene silencing. Biochim Biophys Acta (2004) 1.91
p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene (1999) 1.90
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Involvement of argonaute proteins in gene silencing and activation by RNAs complementary to a non-coding transcript at the progesterone receptor promoter. Nucleic Acids Res (2010) 1.74
Heavy de novo methylation at symmetrical and non-symmetrical sites is a hallmark of RNA-directed DNA methylation. Nucleic Acids Res (1999) 1.62
Efficient regulation of VEGF expression by promoter-targeted lentiviral shRNAs based on epigenetic mechanism: a novel example of epigenetherapy. Circ Res (2009) 1.55
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res (2010) 1.54
Mechanistic principles of chromatin remodeling guided by siRNAs and miRNAs. Cell Cycle (2008) 1.50
Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther (2008) 1.39
In situ fluorescence analysis demonstrates active siRNA exclusion from the nucleus by Exportin 5. Nucleic Acids Res (2006) 1.39
Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J Biotechnol (2006) 1.37
DNA looping induced by a transcriptional enhancer in vivo. Nucleic Acids Res (2005) 1.32
MicroRNAs--targeting and target prediction. N Biotechnol (2010) 1.30
Transcriptional regulation by small RNAs at sequences downstream from 3' gene termini. Nat Chem Biol (2010) 1.25
From bacteria to humans, chromatin to elongation, and activation to repression: The expanding roles of noncoding RNAs in regulating transcription. Crit Rev Biochem Mol Biol (2009) 1.23
Activation of LDL receptor expression by small RNAs complementary to a noncoding transcript that overlaps the LDLR promoter. Chem Biol (2010) 1.20
XIST RNA associates with specific regions of the inactive X chromatin. J Biol Chem (2000) 1.14
Comparison and integration of target prediction algorithms for microRNA studies. J Integr Bioinform (2010) 1.12
Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol (2001) 1.12
Predicting potential miRNA target sites within gene promoters. Bioorg Med Chem Lett (2009) 1.10
Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol (2010) 1.09
Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cells. Cancer Lett (2008) 1.03
E-cadherin intron 2 contains cis-regulatory elements essential for gene expression. Development (2005) 1.00
Effect of chemical modifications on modulation of gene expression by duplex antigene RNAs that are complementary to non-coding transcripts at gene promoters. Nucleic Acids Res (2010) 0.97
Enhancing the efficiency of transgene expression. Philos Trans R Soc Lond B Biol Sci (1993) 0.96
Double stranded-RNA-mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma. Int J Cancer (2009) 0.94
Double strand RNA-guided endogeneous E-cadherin up-regulation induces the apoptosis and inhibits proliferation of breast carcinoma cells in vitro and in vivo. Cancer Sci (2010) 0.91
Hybridization of chromosomal RNA to native DNA. Proc Natl Acad Sci U S A (1969) 0.91
p21WAF1/CIP1 gene transcriptional activation exerts cell growth inhibition and enhances chemosensitivity to cisplatin in lung carcinoma cell. BMC Cancer (2010) 0.91
Up-regulation of E-cadherin by small activating RNA inhibits cell invasion and migration in 5637 human bladder cancer cells. Biochem Biophys Res Commun (2008) 0.91
Selective control of DNA helix openings during gene regulation. Cancer Res (1976) 0.90
Suppression of migration and invasion of PC3 prostate cancer cell line via activating E-cadherin expression by small activating RNA. Cancer Invest (2010) 0.87
MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc Natl Acad Sci U S A (2008) 6.38
Small dsRNAs induce transcriptional activation in human cells. Proc Natl Acad Sci U S A (2006) 4.90
Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab (2009) 2.87
Upregulation of Cyclin B1 by miRNA and its implications in cancer. Nucleic Acids Res (2011) 1.84
RNAa is conserved in mammalian cells. PLoS One (2010) 1.81
Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway. Clin Cancer Res (2006) 1.73
Intravesical delivery of small activating RNA formulated into lipid nanoparticles inhibits orthotopic bladder tumor growth. Cancer Res (2012) 1.65
Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res (2008) 1.58
Prognostic value and function of KLF4 in prostate cancer: RNAa and vector-mediated overexpression identify KLF4 as an inhibitor of tumor cell growth and migration. Cancer Res (2010) 1.54
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells. Oncotarget (2010) 1.53
The E-cadherin -160 C/A polymorphism and prostate cancer risk in white and black American men. J Urol (2006) 1.43
Antitumor effect of dsRNA-induced p21(WAF1/CIP1) gene activation in human bladder cancer cells. Mol Cancer Ther (2008) 1.39
Increased heparanase expression is caused by promoter hypomethylation and up-regulation of transcriptional factor early growth response-1 in human prostate cancer. Clin Cancer Res (2005) 1.25
Cystic fibrosis airway epithelial cell polarity and bacterial flagellin determine host response to Pseudomonas aeruginosa. Cell Microbiol (2004) 1.24
Hsp70B' regulation and function. Cell Stress Chaperones (2007) 1.19
Multigene methylation analysis for detection and staging of prostate cancer. Clin Cancer Res (2005) 1.18
Ago1 Interacts with RNA polymerase II and binds to the promoters of actively transcribed genes in human cancer cells. PLoS Genet (2013) 1.18
Smoking influences aberrant CpG hypermethylation of multiple genes in human prostate carcinoma. Cancer (2006) 1.17
Effects of transplantation of adipose tissue-derived stem cells on prostate tumor. Prostate (2010) 1.15
Cytochrome P450 1B1 is overexpressed and regulated by hypomethylation in prostate cancer. Clin Cancer Res (2005) 1.14
A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins. Biochem Biophys Res Commun (2007) 1.09
Defining features and exploring chemical modifications to manipulate RNAa activity. Curr Pharm Biotechnol (2010) 1.09
Functional Loss of the gamma-catenin gene through epigenetic and genetic pathways in human prostate cancer. Cancer Res (2005) 1.09
Cell number-dependent regulation of Hsp70B' expression: evidence of an extracellular regulator. J Cell Physiol (2007) 1.07
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer (2005) 1.06
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res (2004) 1.05
Epigenetic modifications of RASSF1A gene through chromatin remodeling in prostate cancer. Clin Cancer Res (2007) 1.01
CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer. Cancer (2005) 1.00
Epigenetic inactivation of the dioxin-responsive cytochrome P4501A1 gene in human prostate cancer. Cancer Res (2006) 0.96
Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth. Prostate (2013) 0.95
Double stranded-RNA-mediated activation of P21 gene induced apoptosis and cell cycle arrest in renal cell carcinoma. Int J Cancer (2009) 0.94
Targeted p21WAF1/CIP1 activation by RNAa inhibits hepatocellular carcinoma cells. Nucleic Acid Ther (2012) 0.94
Chromatin changes on the GSTP1 promoter associated with its inactivation in prostate cancer. Mol Carcinog (2007) 0.94
Induction of NANOG expression by targeting promoter sequence with small activating RNA antagonizes retinoic acid-induced differentiation. Biochem J (2012) 0.93
miR-663 induces castration-resistant prostate cancer transformation and predicts clinical recurrence. J Cell Physiol (2014) 0.93
Comparison of open surgery versus retroperitoneoscopic approach to chyluria. J Urol (2003) 0.92
Hsp70B' regulation and function. Cell Stress Chaperones (2007) 0.91
Formulation of Small Activating RNA Into Lipidoid Nanoparticles Inhibits Xenograft Prostate Tumor Growth by Inducing p21 Expression. Mol Ther Nucleic Acids (2012) 0.91
Identification of an aberrant cell line among human adipose tissue-derived stem cell isolates. Differentiation (2008) 0.91
Retroperitoneal laparoscopic nephron-sparing surgery for renal tumors: report of 32 cases. Urology (2005) 0.89
An orthotopic bladder tumor model and the evaluation of intravesical saRNA treatment. J Vis Exp (2012) 0.87
miRNA goes nuclear. RNA Biol (2012) 0.87
Relationship between glucocorticoid receptor signal pathway and androgen-independent prostate cancer. Urol Int (2008) 0.86
Bidirectional TSH and IGF-1 receptor cross talk mediates stimulation of hyaluronan secretion by Graves' disease immunoglobins. J Clin Endocrinol Metab (2014) 0.85
Comparison of retroperitoneoscopic nephrectomy versus open approaches to nonfunctioning tuberculous kidneys: a report of 44 cases. J Urol (2005) 0.84
CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer. Mol Carcinog (2002) 0.84
Retroperitoneoscopic subcapsular nephrectomy for infective nonfunctioning kidney with dense perinephric adhesions. BJU Int (2004) 0.84
Small RNA and its application in andrology and urology. Transl Androl Urol (2012) 0.84
MicroRNA regulation of neuron-like differentiation of adipose tissue-derived stem cells. Differentiation (2009) 0.82
Association between a C/A single nucleotide polymorphism of the E-cadherin gene promoter and transitional cell carcinoma of the bladder. J Urol (2003) 0.81
Meaningful interpretation of subdiffusive measurements in living cells (crowded environment) by fluorescence fluctuation microscopy. Curr Pharm Biotechnol (2010) 0.81
Sphingosine phosphate lyase regulates myogenic differentiation via S1P receptor-mediated effects on myogenic microRNA expression. FASEB J (2013) 0.80
Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells. Stem Cells Dev (2014) 0.80
Adaptation and clonal selection models of castration-resistant prostate cancer: current perspective. Int J Urol (2012) 0.80
saRNA guided iNOS up-regulation improves erectile function of diabetic rats. J Urol (2013) 0.79
Kidney gene database: a curated and integrated database of genes involved in kidney disease. J Urol (2004) 0.78
RNAa in action: from the exception to the norm. RNA Biol (2014) 0.78
Transforming growth factor-beta(s) and their receptors in aging rat prostate. Biochem Biophys Res Commun (2002) 0.75